NASDAQ$ZYXIQ
Zynex Inc · Q3 2024 earnings
Q3 2024 earnings · · Investor relations
Briefing
Zynex's financial performance remained steady with revenue and earnings aligning with guidance, and orders increasing year-over-year.
Zynex reported a 13% year-over-year increase in orders for Q3 2024. The company's revenue and earnings were within the provided guidance. They also received FDA clearance for their new TensWave device.
- Q3 2024 orders increased 13% year-over-year.
- Q3 2024 net revenue reached $50.0 million.
- Q3 2024 net income was $2.4 million, with a diluted EPS of $0.07.
- Q3 2024 cash flow from operations totaled $7.1 million.
Headline financials
Revenue & EPS history
Zynex · Revenue · Quarterly
$50M
Revenue by segment
Zynex · $49.9M total across 2 segments · Q3 2023
- Supplies$33.1M—66.2%
- Devices$16.9M—33.8%
Forward guidance
Zynex anticipates continued diversification of pain management revenue with new therapy products and expects to return to approximately 20% top-line growth in the pain management division in 2025. Fourth quarter 2024 revenue is estimated to be at least $53.6 million with Diluted EPS is estimated to be at least $0.09. The Company expects 2024 net revenue of at least $200 million and Diluted EPS is expected to be at least $0.20 per share.
Tailwinds
- Introduction of new therapy products to diversify revenue stream.
- Aggressive product promotion by the salesforce to ensure sustained profitable growth.
- Expected return to approximately 20% top-line growth in the pain management division in 2025.
- Fourth quarter 2024 revenue is estimated to be at least $53.6 million
- Fourth quarter Diluted EPS is estimated to be at least $0.09
Headwinds
- No specific negatives were mentioned in the provided report.
- However, general risks include obtaining CE marking of new products, acceptance of products by doctors and hospitals,
- competition from larger entities, keeping pace with technological changes,
- dependence on reimbursement from health insurance companies, and reliance on third-party manufacturers.
- Economic factors, such as interest rate fluctuations
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 18 quarterly earnings reports · overlaid with Q3 2024
+0.4%
Avg return
Earnings day
-1.8%
Avg return
5 days after
-6.5%
Avg return
30 days after
46%
29 / 63 earnings
Positive
+38.5%
Q3 2014
Best reaction
-51.6%
Q1 2010
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q4 2024 | -51.3% | — | — | |
| Q3 2025 | +0.0% | +0.0% | -98.2% | |
| Q2 2025 | +0.0% | +0.0% | +0.0% | |
| Q1 2025 | -25.6% | +0.0% | +0.0% | |
| Q3 2024 | +9.1% | +0.0% | +0.0% | |
| Q2 2024 | -11.4% | +0.0% | +0.0% | |
| Q1 2024 | +2.8% | +0.0% | +0.0% | |
| Q4 2023 | -8.8% | +0.0% | +0.0% | |
| Q3 2023 | +17.5% | +0.0% | +0.0% | |
| Q2 2023 | +3.3% | +0.0% | +0.0% | |
| Q1 2023 | +2.5% | +0.0% | +0.0% | |
| Q4 2022 | +16.7% | +0.0% | +0.0% | |
| Q3 2022 | +15.0% | +0.0% | +0.0% | |
| Q2 2022 | +13.3% | +0.0% | +0.0% | |
| Q1 2022 | -8.6% | +0.0% | +0.0% | |
| Q4 2021 | -1.7% | +0.0% | +0.0% | |
| Q3 2021 | +10.0% | +0.0% | +0.0% | |
| Q2 2021 | -19.3% | +0.0% | +0.0% | |
| Q1 2021 | -9.2% | -12.0% | -6.3% | |
| Q4 2020 | -21.2% | -22.4% | -18.8% | |
| Q3 2020 | -6.5% | — | — | |
| Q2 2020 | -6.0% | — | — | |
| Q1 2020 | -1.1% | — | — | |
| Q4 2019 | +3.1% | — | — | |
| Q3 2019 | -7.9% | — | — | |
| Q2 2019 | +9.8% | — | — | |
| Q1 2019 | +7.9% | — | — | |
| Q4 2018 | -11.1% | — | — | |
| Q3 2018 | +3.4% | — | — | |
| Q2 2018 | -3.3% | — | — | |
| Q1 2018 | +4.5% | — | — | |
| Q4 2017 | -20.7% | — | — | |
| Q3 2017 | +6.6% | — | — | |
| Q2 2017 | +34.6% | — | — | |
| Q1 2017 | -5.6% | — | — | |
| Q4 2016 | +9.7% | — | — | |
| Q3 2016 | +23.1% | — | — | |
| Q2 2016 | +34.8% | — | — | |
| Q1 2016 | +0.0% | — | — | |
| Q4 2015 | +0.0% | — | — | |
| Q3 2015 | -4.3% | — | — | |
| Q2 2015 | -5.4% | — | — | |
| Q4 2014 | +0.0% | — | — | |
| Q1 2015 | +0.0% | — | — | |
| Q3 2014 | +38.5% | — | — | |
| Q2 2014 | +2.2% | — | — | |
| Q1 2014 | -0.2% | — | — | |
| Q4 2013 | -3.6% | — | — | |
| Q3 2013 | +13.6% | — | — | |
| Q2 2013 | +7.1% | — | — | |
| Q1 2013 | +0.0% | — | — | |
| Q4 2012 | +3.4% | — | — | |
| Q3 2012 | +5.6% | — | — | |
| Q2 2012 | -5.1% | — | — | |
| Q1 2012 | -6.3% | — | — | |
| Q4 2011 | +0.0% | — | — | |
| Q3 2010 | +12.9% | — | — | |
| Q3 2011 | +12.9% | — | — | |
| Q2 2011 | +1.1% | — | — | |
| Q1 2011 | -8.2% | — | — | |
| Q4 2010 | +0.0% | — | — | |
| Q2 2010 | +2.0% | — | — | |
| Q1 2010 | -51.6% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro